Activin A, a multifunctional cytokine of transforming growth factor-β (TGF-β) superfamily, can be produced by the diverse immune cells. NK cells in peripheral blood are one of the major immune cells applied to cancer therapy in recent years. However, whether activin A can be produced by natural killer (NK) cells and be involved in regulation of peripheral blood NK cells activities of mouse are not well characterized. Here, we found that activin type IIA and IIB receptors and signaling molecules Smad2, 3 were expressed in peripheral blood NK cells of mouse by flow cytometry and RT-PCR. The cultured blood NK cells of mouse not only produced activin βA chain protein by intracellular cytokine staining, but also secreted mature activin A protein by enzyme-linked immunosorbent assay (ELISA), and the production was promoted by IL-2. In addition, IL-2 as a positive control obviously promoted IFNγ production of mouse blood NK cells in vitro. However, activin A suppressed IFNγ production, but enhanced IL-2 synthesis and did not alter IL-10 production. Moreover, we found that activin A significantly suppressed the ability of NK cells to lyse target cells. These data revealed that blood NK cells of mouse were not only the target cells in response to activin A, but also the source of activin A, suggesting that activin A may play an important role in regulation of NK cells activities of mouse in an autocrine / paracrine manner.
Introduction
Activin A, a multifunctional cytokine of transforming growth factor-β (TGF-β) superfamily, is widely expressed in various tissues [1, 2] , and elicits an effect on the regulation of cells proliferation, differentiation and apoptosis, embryonic development, bone remodeling, inflammatory response and protection of neurons [3] [4] [5] [6] [7] . Up till now, there are at least three active forms of activin molecules, activin A (βAβA), activin B (βBβB) and activin AB (βAβB), all of which are homologous dimers or heterologous dimers composed of two inhibin beta chains. Their bioactivities are similar, however, activin A is the most widely distributed [8] [9] [10] . As other members of TGF-β superfamily, activin initially binds to activin type II receptor (ActRII), and then recruits activin type I receptor (ActRI). The activated ActRI further phosphorylates Smad2 and Smad3, which then forms a complex with Smad4. The complex of Smad2, 3, 4 translocates into nucleus to induce the transcription of target gene [11] [12] [13] [14] .
As an important type of innate immune cells, natural killer (NK) cells are the first line of defense against invasion of foreign pathogens and removal of malignant cells in the body, and possess the characters of cytotoxic effect and release of cytokines [15] [16] [17] . NK cells are involved in a variety of diseases development, including tumorigenesis, autoimmune disease, diabetes, rheumatoid arthritis and tissue fibrosis [18] [19] [20] [21] . Previous studies have reported that activin A can be produced by dendritic cells (DC), and is an important mediator of NK-dendritic cell functional interactions [22, 23] . NK cells in peripheral blood are one of the major immune cells applied to cancer therapy in recent years. However, whether activin A can be produced by NK cells and affect activities of peripheral blood NK cells of mouse are still unclear. Therefore, the activin A production of peripheral blood NK cells of mouse were examined, and cytotoxicity and cytokine production of activin A-treated NK cells were further investigated in the present study.
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Isolation of NK cells from peripheral blood of mouse
The peripheral blood NK cells were isolated from peripheral blood with CD49b positive magnetic beads as described previously [24] . Briefly, mononuclear cells of peripheral blood from BALB/c mice were obtained at centrifugation of 1200 rpm for 20 min after treated with 70% Percoll. Then the middle suspensions were collected and cultured in 10% fetal calf serum (FCS)-RPMI 1640 medium in 5% CO 2 at 37°C for 2 h to deplete the adherent monocytes/macrophages [25] . At last, peripheral blood NK cells were enriched using EasySep™ mouse CD49b positive selection kit according to the manufacturer's protocol (StemCell Technologies). Enrichment of the NK cells was further confirmed by flow cytometric analysis with anti-CD49b and NKp46 antibodies.
Assay of NK cells from lymph node and spleen of mouse
The mouse inguinal lymph nodes and spleens were dissected and mechanically ground into a single cell suspension. Mononuclear cells were collected with 70% Percoll, and then the percentage of ActRIIA+ and ActRIIB+ NK cells were analyzed by flow cytometry.
RT-PCR
Total RNA from blood NK cells was extracted using the TRIzol reagent, according to the manufacturer's instructions. RNA was reversetranscribed into cDNA using the PrimeScript™ 1st StrandcDNA Synthesis Kit (Takara). Primers sequences were available upon Table 1 and PCR kit (Takara) was used to amplify specific cDNA. The amplified products were separated by 1.5% agarose gel electrophoresis and the specific cDNA bands were analyzed using Pharmacia Biotech Image Analyzer (Pharmacia Biotech Company).
ELISA for activin A
The isolated peripheral blood NK cells of 1 × 10 5 /well/96 well plate were incubated in the absence or the presence of 5 ng/ml interleukin-2 (IL-2) for 6-24h. The supernatants of the cultured NK cells were collected, and the levels of activin A were examined by enzymelinked immunosorbent assay (ELISA) kit according to the manufacturer's protocol (R&D).
Intracellular cytokine staining
Peripheral blood NK cells were incubated for 2 h in the presence of IL-2 (5 ng/ml) or activin A (5 and 10 ng/ml) in 5% CO 2 saturated humidity incubator at 37°C. After washing with phosphate-buffered saline (PBS) for three times, the cells were stimulated with PMA (50 ng/ml), monensin (2 µmol/L) and ionomycin (1 µmol/L) for 4 h. Then the cells were stained with PE-labeled anti-mouse CD49b antibody and PercpCy5.5-labeled anti-mouse CD3 antibody for 30 min. Fixed with 4% paraformaldehyde for 20 min, the cells were incubated with Foxp3 staining buffer set (eBioscience) for 1 h. Then the cells were stained with FITC-labeled anti-mouse IFN-γ, IL-2 and IL-10 antibodies for 30 min, respectively. The cells were acquired with FACSCalibur flow cytometry (BD Biosciences) and the data was analyzed using FlowJo 7.6 software. 
Analysis of NK cells cytotoxicity

Statistical analysis
All data are expressed as means ± S.D. Statistical comparisons were performed using one-way analysis of variance, followed by Scheffe's test using SPSS 19.0 software (IBM Corp., Armonk, NY, USA), and the values of P < 0.05 were considered statistically significant.
Results
Expressions of activin βA, ActRIIB and Smads mRNA in blood NK cells of mouse
First, the enrichment of peripheral NK cells were confirmed by flow cytometric analysis stained with anti-CD49b and NKp46 antibodies (Fig. 1A) . The results of flow cytometry revealed that the isolated cells with both CD49b and NKp46 positive are over 92.4%, suggesting that the most isolated cells are NK cells. Moreover, the results of RT-PCR showed that not only activin βA mRNA, but also its receptor ActRIIB and signal molecules of Smad2, 3, 4 mRNA were expressed in peripheral blood NK cells of mouse (Fig. 1B) , suggesting that peripheral blood NK cells of mouse may not only respond to activin A, but also release activin A.
Expressions of activin βA protein in blood NK cells of mouse
In order to explore whether peripheral blood NK cells of mouse can produce activin A, Activin βA chain protein expressions in NK cells were analyzed by flow cytometry with intracellular cytokine staining. , culture medium control; ■, 10 ng/ml IL-2. All the data represented triplicate experiments. * p < 0.05, * * p < 0.01, compared with 0 control group (n = 9).
The results showed that activin βA chain protein existed not only in CD3-CD49b+ NK cells, but also in CD3-CD49b+NKp46 + NK cells, and there was no significant difference of the percentage of cells expressing activin βA chain protein between CD3-CD49b+ NK cells and CD3-CD49b+NKp46 + NK cells (Fig. 2) .
The release of activin A from blood NK cells of mouse
In order to confirm that NK cells can produce the mature activin A protein, the isolated NK cells from peripheral blood of mouse were treated with IL-2 in vitro and the mature activin A protein in the supernatants of the cultured NK cells was examined by ELISA. The result showed that not only activin A was produced by cultured blood NK cells in vitro, but also the release of activin A from NK cells was promoted by IL-2 in a dose-dependent manner and time-dependent manner (Fig. 3) . These data indicated that blood NK cells of mouse were the source of activin A.
Expression of activin receptors in NK cells of mouse
Previous studies have reported that activin receptors are expressed in human NK cells [22] . In order to illuminate that NK cells of mouse not only can secret activin A, but also are the target cells in response to activin A, expressions of ActRIIA and ActRIIB on peripheral blood NK cells of mouse were examined by flow cytometry. The results showed that the CD3-CD49b+ NK cells in peripheral blood of mouse expressed both ActRIIA and ActRIIB (Fig. 4A) . Further results revealed that NK cells derived from tissues also expressed ActRIIA (Fig. 4B) . Activin A initially binds to activin type II receptor (ActRIIA or ActRIIB), and then induces the transcription of target gene [12] [13] [14] . Fig. 1B showed Smads, the downstream molecules of activin, were expressed in NK cells as well. Thus, the above data suggest that the peripheral blood NK cells of mouse are also the target cells in response to activin A. 
Effects of activin A on production of IFNγ, IL-2 and IL-10 of blood NK cells
In order to determine activin A function, the production of IFNγ, IL-2 and IL-10 of NK cells was examined by intracellular cytokine staining. The results showed that IL-2 as a positive control obviously promoted blood NK cells IFNγ production of mouse, while activin A inhibited IFNγ production of blood NK cells significantly, which was similar to the effect of activin A on human NK cells [22] . Moreover, the results showed that activin A notably increased blood NK cells IL-2 levels, but did not alter the IL-10 production significantly (Fig. 5 ).
The neutralizing effects of follistatin to activin A on NK cells IFNγ and IL-2 production
Follistatin (FS) can neutralize the bioactivities of activin by blocking the binding of activin to ActRII. Therefore, the effects of FS on activin A activity were observed. The results showed that FS blocked the effect of activin A on IL-2 and INF-γ secretion (Fig. 6) , suggesting that FS blocked the binding site of activin to ActRII.
Inhibitory effects of activin A on blood NK cells cytotoxicity and proliferation
Besides the function of cytokines synthesis and secretion, NK cells possess the character of cytolytic function. In this study, blood NK cell cytotoxicity was analyzed by LDH releasing method and the amount of YAC-1 cells was counted. The results showed that IL-2 as a positive control significantly increased the release of LDH and the killing rate of YAC-1 cells by NK cells. Conversely, activin A inhibited the release of LDH and the killing rate of YAC-1 cells (Fig. 7A and B) . The results indicated that IL-2 significantly enhanced the ability of blood NK cells of mouse to lyse target cells YAC-1 cells, while activin A suppressed the ability of NK cells to lyse target cells. 
Discussion
Activin A can be secreted by a variety of immune cells, including Th2 cells, microglia/macrophages, dendritic cells, mast cells and neutrophils [23, [26] [27] [28] [29] . As an important cytokine, activin A is involved in a variety of physiological and pathological processes [30] [31] [32] . Recent studies have reported that activin A is a vital modulator to mediate the interaction of dendritic cells and NK cells, and inhibits human NK cells INF-γ production [22, 23] . In this study, we found that activin βA mRNA is expressed in blood NK cells of mouse, and activin βA chain protein production in blood NK cells was also observed by the intracellular cytokine staining. Moreover, the mature activin A protein in the supernatants of the cultured NK cells was also detectable by ELISA, which was promoted with IL-2 treatment in a dose-dependent manner. These data indicated that blood NK cells of mouse are capable of producing activin A.
Previous study has reported that activin receptors and downstream signaling molecules Smads exist in human NK cells [22] . Therefore, in order to confirm blood NK cells of mouse can also respond to activin A, expression of activin receptors was first examined by flow cytometry in the present study. We found that blood NK cells of mouse express not only CD49b, a biomarker of mouse NK cells, but also ActRIIA and ActRIIB. ActRIIA expression can also be observed on CD49b positive NK cells from spleen and lymph node. Meanwhile, the expressions of ActRIIB and Smad2, 3, 4 mRNA were also detectable in blood NK cells of mouse. These results suggested that blood NK cells of mouse have the ability to respond to activin A, which is similar to human NK cells.
Activin A level in normal human serum is no more than 1 ng/ml, which is not enough to affect the activity of NK cells. But in pregnancy and pathological condition, the serum activin A level can reach over 10 ng/ml [33] . Moreover, the activin A level was lower in vitro, but the concentration of activin A secreted by NK cells in tissue in pathological conditions was significantly increased in vivo [34] , suggesting that activin A may play a paracrine role in tissues, especially in pregnancy and pathological conditions. Therefore, 5-10 ng/ml of activin A was used in the following experiments, which is similar to pathological condition of human body.
NK cells are the important innate immune cells that can secrete IFNγ, IL-2 and other cytokines involved in the process of innate immunity and acquired immunity [35, 36] . Therefore, mouse blood NK cells IFNγ, IL-2 and IL-10 productions were assessed by intracellular cytokine staining. We found that as a positive control, IL-2 promoted blood NK cells IFNγ production of mouse, while activin A suppressed blood NK cells IFNγ production, which was similar to the results of human NK cells [22] . Furthermore, activin A obviously enhanced NK cells IL-2 synthesis, but did not influence IL-10 production. IL-2 secreted by NK cells can promote immunity (activating Th cells), while IL-10 mainly plays an immunosuppressive role (inhibiting Th cells). Therefore, Activin A may promote the immune regulation of NK cells by increasing the secretion of IL-2.
To further confirm the effects of activin A on the secretion of IFNγ and IL-2, we used follistatin (FS), an activin-binding protein, to neutralize the bioactivities of activin. FS can specifically bind activin as a soluble protein [37] , appearing to act by blocking the binding of activin to ActRII and directly neutralizing the biological activity of activin [38, 39] . In this study, our results showed that FS neutralized the effects activin A on NK cells IFNγ and IL-2 production. Taken together, we can get a conclusion that activin A might play an important regulatory role in NK cells cytokines production via ActRII, which can be blocked by FS.
Besides the secretion function of cytokines, NK cells are important killer cells in the body, and special stimulus, such as IL-2, can induce NK cells proliferation [40] . Therefore, in the present study, LDH release method was used to determine the ability of mouse NK cells to kill mouse tumor cells YAC-1. The results revealed that IL-2 promoted the activities of NK cells to kill YAC-1 cells. Conversely, activin A inhibited the ability of NK cells to kill target cells. Thus it is speculated that as a regulating factor, activin A may reduce tissue damage via inhibiting NK cells cytotoxicity, and influence inflammatory processes by regulating NK cells cytokine production.
Conclusions
In this study, activin receptors and signaling molecules Smads are expressed in mouse blood NK cells which can produce activin A, suggesting that blood NK cells of mouse are not only the source of activin A, but also the target cells in response to activin A. Moreover, activin A can regulate production of NK cells cytokines and inhibit NK cells cytotoxicity, further confirming that activin A as a vital regulator may elicit an effect on NK cells activities in an autocrine/paracrine manner.
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